Your browser is old and is not supported. Upgrade for better security.

Invest in Entelexo (YC W21)

Creating a new class of drugs to address incurable autoimmune diseases

Pitch Video
Investor Panel

Highlights

1
>$1M raised to date, plus $310k on the same terms
2
CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease
3
Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year
4
Our intellectual property is patent-protected (patent owned by the Company)
5
Raising $2M for pre-clinical product development and IND enabling animal studies

Our Team


Downloads

Overview